These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2324683)

  • 1. Direct diabetogenic effect of diltiazem?
    Iversen E; Jeppesen D; Steensgaard-Hansen F
    J Intern Med; 1990 Apr; 227(4):285-6. PubMed ID: 2324683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paralytic ileus as a result of diltiazem treatment.
    Mantzoros CS; Prabhu AS; Sowers JR
    J Intern Med; 1994 Jun; 235(6):613-4. PubMed ID: 8207368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary mania associated with diltiazem.
    Palat GK; Hooker EA; Movahed A
    Clin Cardiol; 1984 Nov; 7(11):611-2. PubMed ID: 6499291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.
    Ueno S; Hara Y
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):409-10. PubMed ID: 1318359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with diltiazem and propranolol: precipitation of congestive heart failure.
    Strauss WE; Egan T; McIntyre KM; Parisi AF
    Clin Cardiol; 1985 Jun; 8(6):363-6. PubMed ID: 4006348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
    Sellier P; Quilliet L
    Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
    Buckley MM; Grant SM; Goa KL; McTavish D; Sorkin EM
    Drugs; 1990 May; 39(5):757-806. PubMed ID: 2191851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased vagal activity after administration of the calcium antagonist diltiazem in patients with coronary heart disease].
    Frey AW; Müller C; Dambacher M; Theisen K
    Z Kardiol; 1995 Feb; 84(2):105-11. PubMed ID: 7717013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable diltiazem-induced acute interstitial nephritis.
    Abadín JA; Durán JA; Pérez de León JA
    Ann Pharmacother; 1998 Jun; 32(6):656-8. PubMed ID: 9640485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of diltiazem in acute and long-term administration].
    Kram J; Bölter C; Graf B; Urbaszek W
    Z Gesamte Inn Med; 1991 May; 46(7):223-8. PubMed ID: 1910232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of intravenous diltiazem at rest and exercise in patients with coronary artery disease.
    Legrand V; Hastir F; Vandormael M; Collignon P; Kulbertus HE
    Eur Heart J; 1984 Jun; 5(6):456-63. PubMed ID: 6745287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal renal and hepatic toxicity after treatment with diltiazem.
    Shallcross H; Padley SP; Glynn MJ; Gibbs DD
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1236-7. PubMed ID: 3120959
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise.
    Théroux P; Baird M; Juneau M; Warnica W; Klinke P; Kostuk W; Pflugfelder P; Lavallée E; Chin C; Dempsey E
    Circulation; 1991 Jul; 84(1):15-22. PubMed ID: 1905592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem: effects on exercise performance in patients with coronary artery disease.
    Starling MR; Crawford MH; O'Rourke RA
    Int J Cardiol; 1982; 1(3-4):229-37. PubMed ID: 6284661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence consistency across treatment regimens.
    Mason B; Matsuyama J; Jue S
    Diabetes Care; 1994 Apr; 17(4):347-8. PubMed ID: 8026296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem].
    Maranhão MF; de Castro I; Albanesi Filho FM; Bozza A; de Brito AX; Sbissa AS
    Arq Bras Cardiol; 1992 Feb; 58(2):149-55. PubMed ID: 1307461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct myocardial anti-ischemic effect of diltiazem in the human].
    Kober G; Kästner R; Hopf R; Kaltenbach M
    Z Kardiol; 1986 Jul; 75(7):386-93. PubMed ID: 2945332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group.
    Juneau M; Théroux P; Waters D
    Am J Cardiol; 1992 Mar; 69(7):30B-35B. PubMed ID: 1543140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.